Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors

Florian Thaler; Loris Moretti; Raffaella Amici; Agnese Abate; Andrea Colombo; Giacomo Carenzi; Maria Carmela Fulco; Roberto Boggio; Giulio Dondio; Stefania Gagliardi; Saverio Minucci; Luca Sartori; Mario Varasi; Ciro Mercurio

doi:10.1016/j.ejmech.2015.11.010

Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors

Florian Thaler, Loris Moretti, Raffaella Amici, Agnese Abate, Andrea Colombo, Giacomo Carenzi, Maria Carmela Fulco, Roberto Boggio, Giulio Dondio, Stefania Gagliardi, Saverio Minucci, Luca Sartori, Mario Varasi, Ciro Mercurio

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Abstract

In the last decades, inhibitors of histone deacetylases (HDAC) have become an important class of anti-cancer agents. In a previous study we described the synthesis of spiro[chromane-2,4′-piperidine]hydroxamic acid derivatives able to inhibit histone deacetylase enzymes. Herein, we present our exploration for new derivatives by replacing the piperidine moiety with various cycloamines. The goal was to obtain highly potent compounds with a good in vitro ADME profile. In addition, molecular modeling studies unravelled the binding mode of these inhibitors.

Original language	English
Pages (from-to)	53-67
Number of pages	15
Journal	European Journal of Medicinal Chemistry
Volume	108
DOIs	https://doi.org/10.1016/j.ejmech.2015.11.010
Publication status	Published - Jan 27 2016

Keywords

Antiproliferation
Epigenetics
Histone deacetylases
Molecular modeling
Privileged structures

ASJC Scopus subject areas

Drug Discovery
Organic Chemistry
Pharmacology

Access to Document

10.1016/j.ejmech.2015.11.010

Fingerprint Dive into the research topics of 'Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors'. Together they form a unique fingerprint.

Cite this

Thaler, F., Moretti, L., Amici, R., Abate, A., Colombo, A., Carenzi, G., Fulco, M. C., Boggio, R., Dondio, G., Gagliardi, S., Minucci, S., Sartori, L., Varasi, M., & Mercurio, C. (2016). Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. European Journal of Medicinal Chemistry, 108, 53-67. https://doi.org/10.1016/j.ejmech.2015.11.010

Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. / Thaler, Florian; Moretti, Loris; Amici, Raffaella; Abate, Agnese; Colombo, Andrea; Carenzi, Giacomo; Fulco, Maria Carmela; Boggio, Roberto; Dondio, Giulio; Gagliardi, Stefania; Minucci, Saverio; Sartori, Luca; Varasi, Mario; Mercurio, Ciro.

In: European Journal of Medicinal Chemistry, Vol. 108, 27.01.2016, p. 53-67.

Research output: Contribution to journal › Article › peer-review

Thaler, F, Moretti, L, Amici, R, Abate, A, Colombo, A, Carenzi, G, Fulco, MC, Boggio, R, Dondio, G, Gagliardi, S, Minucci, S, Sartori, L, Varasi, M & Mercurio, C 2016, 'Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors', European Journal of Medicinal Chemistry, vol. 108, pp. 53-67. https://doi.org/10.1016/j.ejmech.2015.11.010

Thaler, Florian ; Moretti, Loris ; Amici, Raffaella ; Abate, Agnese ; Colombo, Andrea ; Carenzi, Giacomo ; Fulco, Maria Carmela ; Boggio, Roberto ; Dondio, Giulio ; Gagliardi, Stefania ; Minucci, Saverio ; Sartori, Luca ; Varasi, Mario ; Mercurio, Ciro. / Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. In: European Journal of Medicinal Chemistry. 2016 ; Vol. 108. pp. 53-67.

@article{51fa0ea14c244a7195d5e18e3b998f21,

title = "Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors",

abstract = "In the last decades, inhibitors of histone deacetylases (HDAC) have become an important class of anti-cancer agents. In a previous study we described the synthesis of spiro[chromane-2,4′-piperidine]hydroxamic acid derivatives able to inhibit histone deacetylase enzymes. Herein, we present our exploration for new derivatives by replacing the piperidine moiety with various cycloamines. The goal was to obtain highly potent compounds with a good in vitro ADME profile. In addition, molecular modeling studies unravelled the binding mode of these inhibitors.",

keywords = "Antiproliferation, Epigenetics, Histone deacetylases, Molecular modeling, Privileged structures",

author = "Florian Thaler and Loris Moretti and Raffaella Amici and Agnese Abate and Andrea Colombo and Giacomo Carenzi and Fulco, {Maria Carmela} and Roberto Boggio and Giulio Dondio and Stefania Gagliardi and Saverio Minucci and Luca Sartori and Mario Varasi and Ciro Mercurio",

year = "2016",

month = jan,

day = "27",

doi = "10.1016/j.ejmech.2015.11.010",

language = "English",

volume = "108",

pages = "53--67",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors

AU - Thaler, Florian

AU - Moretti, Loris

AU - Amici, Raffaella

AU - Abate, Agnese

AU - Colombo, Andrea

AU - Carenzi, Giacomo

AU - Fulco, Maria Carmela

AU - Boggio, Roberto

AU - Dondio, Giulio

AU - Gagliardi, Stefania

AU - Minucci, Saverio

AU - Sartori, Luca

AU - Varasi, Mario

AU - Mercurio, Ciro

PY - 2016/1/27

Y1 - 2016/1/27

N2 - In the last decades, inhibitors of histone deacetylases (HDAC) have become an important class of anti-cancer agents. In a previous study we described the synthesis of spiro[chromane-2,4′-piperidine]hydroxamic acid derivatives able to inhibit histone deacetylase enzymes. Herein, we present our exploration for new derivatives by replacing the piperidine moiety with various cycloamines. The goal was to obtain highly potent compounds with a good in vitro ADME profile. In addition, molecular modeling studies unravelled the binding mode of these inhibitors.

AB - In the last decades, inhibitors of histone deacetylases (HDAC) have become an important class of anti-cancer agents. In a previous study we described the synthesis of spiro[chromane-2,4′-piperidine]hydroxamic acid derivatives able to inhibit histone deacetylase enzymes. Herein, we present our exploration for new derivatives by replacing the piperidine moiety with various cycloamines. The goal was to obtain highly potent compounds with a good in vitro ADME profile. In addition, molecular modeling studies unravelled the binding mode of these inhibitors.

KW - Antiproliferation

KW - Epigenetics

KW - Histone deacetylases

KW - Molecular modeling

KW - Privileged structures

UR - http://www.scopus.com/inward/record.url?scp=84948399958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948399958&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2015.11.010

DO - 10.1016/j.ejmech.2015.11.010

M3 - Article

AN - SCOPUS:84948399958

VL - 108

SP - 53

EP - 67

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -